StockData
CAPSNasdaqWholesale-Lumber & Other Construction MaterialsFiscal year ends December 31

Capstone Holding Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Aug 12, 2026
$2.72+0.11 (+4.20%)

Close on Oct 19, 2026

Market cap
$34.39M
P/E (TTM)
–
Dividend yield
–

About Capstone

Wholesale-Lumber & Other Construction Materials, SIC 5030

Capstone Holding Corp. operates a technology-enabled building products distribution and installation platform across North America. Through its operating subsidiaries—Instone, Canadian Stone Industries, and Carolina Stone—the enterprise supplies thin veneer stone, natural stone, manufactured stone, landscape pavers, and related masonry materials. Its operational activities are organized into the Instone/TotalStone and Carolina Stone segments. Capstone distributes materials and provides professional installation services to an active customer base consisting of masonry dealers, brick distributors, landscape yards, building material dealers, commercial contractors, homebuilders, and individual homeowners.

The company maintains nine distribution and warehouse facilities across North America, with operational locations in Massachusetts, New Jersey, Ohio, California, Illinois, North Carolina, British Columbia, and Ontario. Its logistics footprint services construction projects across 38 U.S. states and two Canadian provinces. While the excerpt describes its facilities and corporate office across these regions, a specific city or state for the corporate headquarters is not stated in the provided text.

Summary of the business section of Capstone's latest annual report, written by StockData.

Company profile

Company

Legal name
Capstone Holding Corp.
Founded
2006
Headquarters
Tinley Park, IL
Address
18400 76th Avenue 60477
Phone
(708) 371-0660
Employees
93, Dec 31, 2025
Industry
Wholesale-Lumber & Other Construction Materials
Incorporated in
Nevada
Fiscal year ends
December 31
Auditor
GBQ Partners LLC, Columbus, Ohio

Stock & identifiers

Ticker
CAPS
Exchange
Nasdaq
Shares outstanding
21M, Aug 10, 2026
Filer category
<br>Emerging growth company
Stock splits
1-for-30 reverse, Oct 19, 2026; 1-for-1000 reverse, Sep 10, 2019; 2-for-1, Jun 26, 1996
SEC CIK
887151
CUSIP
14068E208
ISIN
US14068E2081
EIN
86-0585310

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Matthew E. LipmanChief Executive Officer, Director4,143,084
Kevin Allan GrotkePresident & CEO of TotalStone1,041,597
Edward Christopher SchultzChief Financial Officer500,310
Fredric J. FeldmanDirector200,124
Michael ToporekDirector1,614,421
John M. Holliman IiiDirector406,001
Elwood D. HowseDirector200,124
Gordon Lewis Strout JrDirector1,363,938

Employees

Headcount reported in annual reports

“As of December 31, 2025, the Company and its subsidiaries employed approximately 93 full-time employees and 3 independent contractors across our corporate office and nine distribution, warehouse, and installation facilities.”

Corporate history

Events identified from SEC filings

DateEventDetails
May 15, 2026Late filingNotification of late filing
Mar 31, 2026Late filingNotification of late filing
Jan 9, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 2, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 14, 2025Late filingNotification of late filing
Nov 7, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 15, 2025Late filingNotification of late filing
Feb 14, 2025ListingRegistration of securities on an exchange (Form 8-A)
Sep 25, 2019DeregistrationTermination of SEC registration (Form 15)
Sep 25, 2019Name changeName changed from Capstone Therapeutics Corp. to Capstone Holding Corp.
Aug 14, 2017Auditor changeChange in certifying accountant (8-K Item 4.01)
Mar 4, 2016Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 24, 2014DelistingNotice of delisting from exchange (Form 25)
Aug 3, 2012Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 10, 2011DelistingNotice of delisting from exchange (Form 25)
Jul 20, 2011Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 10, 2011Auditor changeChange in certifying accountant (8-K Item 4.01)
May 12, 2011Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 9, 2011Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 12, 2010Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 14, 2010Name changeName changed from ORTHOLOGIC CORP to Capstone Therapeutics Corp.
May 7, 2010Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 5, 2010Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 17, 2009Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 11, 2008Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 25, 2007ListingRegistration of securities on an exchange (Form 8-A)
Jun 22, 2007DeregistrationTermination of SEC registration (Form 15)
Jun 20, 2006Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 3, 2004MergerRegistration of securities for a merger or exchange offer (S-4)
Oct 27, 2003Merger voteDefinitive merger proxy statement